These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28018897)

  • 1. Patient-Centered Tablet Application for Improving Medication Adherence after a Drug-Eluting Stent.
    Shah V; Dileep A; Dickens C; Groo V; Welland B; Field J; Baumann M; Flores JD; Shroff A; Zhao Z; Yao Y; Wilkie DJ; Boyd AD
    Front Public Health; 2016; 4():272. PubMed ID: 28018897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly Medication Adherence Intervention Using the My Interventional Drug-Eluting Stent Educational App: Multisite Randomized Feasibility Trial.
    Boyd AD; Ndukwe CI; Dileep A; Everin OF; Yao Y; Welland B; Field J; Baumann M; Flores JD; Shroff A; Groo V; Dickens C; Doukky R; Francis R; Peacock G; Wilkie DJ
    JMIR Mhealth Uhealth; 2020 Jun; 8(6):e15900. PubMed ID: 32579120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. My Interventional Drug-Eluting Stent Educational App (MyIDEA): Patient-Centered Design Methodology.
    Boyd AD; Moores K; Shah V; Sadhu E; Shroff A; Groo V; Dickens C; Field J; Baumann M; Welland B; Gutowski G; Flores JD; Zhao Z; Bahroos N; Hynes DM; Wilkie DJ
    JMIR Mhealth Uhealth; 2015 Jul; 3(3):e74. PubMed ID: 26139587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the general practice EMR for improving blood pressure medication adherence.
    Warren J; Kennelly J; Warren D; Elley CR; Wai KC; Manukia M; Davy J; Mabotuwana T; Robinson E
    Stud Health Technol Inform; 2012; 178():228-34. PubMed ID: 22797046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center.
    Bidwal M; Lor K; Yu J; Ip E
    Res Social Adm Pharm; 2017; 13(4):759-766. PubMed ID: 27595427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Mobile Health Strategies to Improve Medication Adherence for Veterans With Coronary Heart Disease (Mobile4Meds): Protocol for a Mixed-Methods Study.
    Park LG; Collins EG; Shim JK; Whooley MA
    JMIR Res Protoc; 2017 Jul; 6(7):e134. PubMed ID: 28720557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials.
    Lee SY; Hong MK; Palmerini T; Kim HS; Valgimigli M; Feres F; Colombo A; Gilard M; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Stone GW
    JACC Cardiovasc Interv; 2018 Mar; 11(5):435-443. PubMed ID: 29454730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes following very late stent thrombosis of drug-eluting stent.
    Xu L; Sun H; Wang L; Li K; Zhang D; Chen M; Wang H; Li W; Ni Z; Xia K; Liu Y; Yang X
    J Cardiol; 2015 Dec; 66(6):496-501. PubMed ID: 25881729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an integrated e-health tool for people with, or at high risk of, cardiovascular disease: The Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) web application.
    Neubeck L; Coorey G; Peiris D; Mulley J; Heeley E; Hersch F; Redfern J
    Int J Med Inform; 2016 Dec; 96():24-37. PubMed ID: 26847070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
    Huber CA; Meyer MR; Steffel J; Blozik E; Reich O; Rosemann T
    Clin Ther; 2019 Jan; 41(1):107-117. PubMed ID: 30591287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.
    Gargiulo G; Windecker S; da Costa BR; Feres F; Hong MK; Gilard M; Kim HS; Colombo A; Bhatt DL; Kim BK; Morice MC; Park KW; Chieffo A; Palmerini T; Stone GW; Valgimigli M
    BMJ; 2016 Nov; 355():i5483. PubMed ID: 27811064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Electronic Personal Health Records to Improve Medication Adherence and Patient Engagement: A Randomized Study of Non-valvular Atrial Fibrillation Patients.
    Chen YC; Roebuck AE; Sami A; Ersin ÖH; Mirro MJ
    J Innov Card Rhythm Manag; 2017 Aug; 8(8):2804-2813. PubMed ID: 32494465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention.
    Galper BZ; Reynolds MR; Garg P; Secemsky EA; Valsdottir LR; Cohen DJ; Yeh RW
    Coron Artery Dis; 2019 May; 30(3):177-182. PubMed ID: 30676386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between User Engagement of a Mobile Health App for Gout and Improvements in Self-Care Behaviors: Randomized Controlled Trial.
    Serlachius A; Schache K; Kieser A; Arroll B; Petrie K; Dalbeth N
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e15021. PubMed ID: 31411147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy.
    Tarantini G; Nai Fovino L; Tellaroli P; Chieffo A; Barioli A; Menozzi A; Frasheri A; Garbo R; Masotti-Centol M; Salvatella N; Dominguez JF; Steffanon L; Presbitero P; Pucci E; Fraccaro C; Mauri J; Giustino G; Sardella G; Colombo A
    Int J Cardiol; 2016 Mar; 207():168-76. PubMed ID: 26803236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".
    Kedhi E; Fabris E; van der Ent M; Kennedy MW; Buszman P; von Birgelen C; Cook S; Wedel H; Zijlstra F
    Am Heart J; 2017 Jun; 188():11-17. PubMed ID: 28577666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.
    Waksman R; Piegari GN; Kabour A; Cannon L; Wang J; Adams G; Solankhi N; Smeglin A; Kereiakes DJ; Leiboff R; Spad MA; Torguson R; Chandra N; Bastian R; DeGroot J; Kayo MW; Stoll HP; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2017; 18(7):475-481. PubMed ID: 28923692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.
    Camenzind E; Boersma E; Wijns W; Mauri L; Rademaker-Havinga T; Ordoubadi FF; Suttorp MJ; Al Kurdi M; Steg PG;
    Eur Heart J; 2014 Aug; 35(29):1932-48. PubMed ID: 24627416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial.
    Atreja A; Khan S; Rogers JD; Otobo E; Patel NP; Ullman T; Colombel JF; Moore S; Sands BE;
    JMIR Res Protoc; 2015 Feb; 4(1):e23. PubMed ID: 25693610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.